Ciclopirox Olamine Suspension
Product Images NDC 45802-400

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ciclopirox Olamine (NDC 45802-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1f283rcc6

Packaging label for Ciclopirox Olamine Topical Suspension USP 0.77% (w/w) lotion, 30 mL, by Perrigo. The label includes dosing instructions, storage information, and states the product is for dermatologic use only, not for ophthalmic use. It specifies the active ingredient concentration and provides manufacturer and distributor details.*

FDA Label Image

Image 01

Chemical structure of Ciclopirox Olamine showing the molecular arrangement including a cyclohexane ring, a hydroxyl group attached to a nitrogen, a methyl group, a carbonyl group, and a hydrated ethanolamine moiety.*

FDA Label Image

Serialization Template

A label panel with placeholders for product information including serial number (S/N), lot number, and expiration date (Exp). The label is designed for Ciclopirox Olamine topical suspension 7.7 mg/mL by Padagis Israel Pharmaceuticals Ltd, displaying areas for variable product data to be inserted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.